AKBA
Akebia Therapeutics, Inc.stockNASDAQ
At CloseNov 13, 2026 3:59:41 PM EST
0.47USD-5.161%(-0.03)3,887,612
Pre-marketNov 13, 2026 9:22:30 AM EST
0.4998USD+0.361%(+0.0018)
After-hoursNov 13, 2026 4:47:30 PM EST
0.4805USD+1.736%(+0.0082)
AKBA Financials
In Q3 FY 2026 (ended ), Akebia Therapeutics, Inc. (AKBA) reported revenue of $36.9M, net income of −$14.35M, operating cash flow of $2.33M, and assets of $342.13M (filed ).
Loading financial flows…
